Controlled reperfusion after myocardial ischemia in a canine model monitored by two-dimensional phosphorus 31 chemical shift spectroscopic imaging

Am Heart J. 1997 May;133(5):508-16. doi: 10.1016/s0002-8703(97)70145-5.

Abstract

Phosphorus 31 magnetic resonance spectroscopy at 2 T was used to monitor high-energy phosphate metabolism over a 3-week period in a canine model of myocardial infarction and reperfusion. Twenty animals were divided into two groups: group 1 (n = 11) received intravenous nitroglycerin beginning at the onset of coronary occlusion; group 2 (n = 9) received a 105-minute infusion of superoxide dismutase (SOD) beginning at the onset of reperfusion. A metabolic protective effect was observed (vs controls) with both agents, manifested by a reduction in the degree of pH decline from baseline values and preservation of the adenosine triphosphate/total phosphate ratio during occlusion and reperfusion. Further, both treatments, compared with controls, produced a lower infarct/zone at risk ratio: controls, 1.5 +/- 1.2; nitroglycerin, 0.52 +/- 0.50; and SOD, 0.64 +/- 0.40. The technique of 31P magnetic resonance spectroscopy demonstrated its use for the noninvasive assessment of myocardial metabolism in response to therapeutic intervention.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Contrast Media
  • Dogs
  • Female
  • Free Radical Scavengers / administration & dosage
  • Free Radical Scavengers / therapeutic use*
  • Gadolinium DTPA
  • Hydrogen-Ion Concentration
  • Infusions, Intravenous
  • Magnetic Resonance Spectroscopy / methods
  • Myocardial Reperfusion / methods*
  • Myocardial Reperfusion Injury / diagnosis*
  • Myocardial Reperfusion Injury / metabolism
  • Myocardial Reperfusion Injury / prevention & control*
  • Myocardium / metabolism*
  • Nitroglycerin / administration & dosage
  • Nitroglycerin / therapeutic use*
  • Organometallic Compounds
  • Pentetic Acid / analogs & derivatives
  • Phosphates / metabolism
  • Phosphocreatine / metabolism
  • Superoxide Dismutase / administration & dosage
  • Superoxide Dismutase / therapeutic use*
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use*

Substances

  • Contrast Media
  • Free Radical Scavengers
  • Organometallic Compounds
  • Phosphates
  • Vasodilator Agents
  • Phosphocreatine
  • Pentetic Acid
  • Adenosine Triphosphate
  • Superoxide Dismutase
  • Nitroglycerin
  • Gadolinium DTPA